
A study presented at the Eleventh International Congress of the International Psychogeriatric Association showed that risperidone 1 mg/day reduced the risk of falls in ambulatory patients with dementia. Data from 537 patients in a randomized, double-blind, placebo-controlled, 12-week, multicenter study of three doses of risperidone were included.